ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesChapter 12: Diseases of the skin and subcutaneous tissueL65

L65

Non-billable

Other nonscarring hair loss

Chapter 12:Diseases of the skin and subcutaneous tissue

BILLABLE STATUSNo
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 L65 is a used to indicate a diagnosis of other nonscarring hair loss.

Key Diagnostic Point:

ICD-10 code L65 encompasses a variety of conditions characterized by nonscarring hair loss, which includes types such as telogen effluvium, alopecia areata, and other forms of hair thinning or loss that do not result in scarring of the scalp. These conditions can arise from various factors, including hormonal changes, nutritional deficiencies, stress, and autoimmune responses. Clinically, it is essential to differentiate nonscarring hair loss from scarring types, as the management and prognosis can vary significantly. The diagnosis often requires a thorough clinical evaluation, including patient history and sometimes laboratory tests to identify underlying causes.

  • The clinical significance of L65 lies in its broad coverage of hair loss conditions that are not permanent and can often be reversible with appropriate treatment. Usage guidelines suggest that L65 should be employed when documenting cases of hair loss that lack scarring, allowing healthcare providers to communicate the nature of the condition effectively. This category is vital for tracking the prevalence of nonscarring hair loss in the population and ensuring that patients receive the necessary interventions to address their symptoms and improve their quality of life.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variety of conditions covered
  • Need for differential diagnosis
  • Potential for overlapping symptoms with other categories

Audit Risk Factors

  • Inadequate documentation of underlying causes
  • Misdiagnosis leading to incorrect coding
  • Failure to follow up on treatment outcomes

Specialty Focus

Medical Specialties

Dermatology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Primary Care

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The clinical impact of L65 is significant, as it addresses a common concern among patients experiencing hair loss, which can affect their psychological well-being and quality of life. Understanding and accurately coding nonscarring hair loss conditions can lead to better management strategies and improved patient outcomes. From an administrative perspective, tracking the prevalence of these conditions can inform healthcare trends and resource allocation, ultimately enhancing the quality of care provided.
Additionally, as awareness of mental health and its connection to physical conditions grows, addressing nonscarring hair loss becomes increasingly relevant in quality measures. This category not only highlights the need for comprehensive care but also emphasizes the importance of preventive measures and early intervention in managing hair loss effectively.

ICD-9 vs ICD-10

The clinical impact of L65 is significant, as it addresses a common concern among patients experiencing hair loss, which can affect their psychological well-being and quality of life. Understanding and accurately coding nonscarring hair loss conditions can lead to better management strategies and improved patient outcomes. From an administrative perspective, tracking the prevalence of these conditions can inform healthcare trends and resource allocation, ultimately enhancing the quality of care provided. Additionally, as awareness of mental health and its connection to physical conditions grows, addressing nonscarring hair loss becomes increasingly relevant in quality measures. This category not only highlights the need for comprehensive care but also emphasizes the importance of preventive measures and early intervention in managing hair loss effectively.

Reimbursement & Billing Impact

Reimbursement considerations include the necessity of providing detailed documentation that justifies the diagnosis and treatment plan. Common billing practices involve ensuring that the services rendered align with the diagnosis codes submitted, as discrepancies can lead to claim denials or delays in payment.

Resources

Clinical References

  • •
    Official ICD-10 Guidelines for L65

Coding & Billing References

  • •
    Official ICD-10 Guidelines for L65

Frequently Asked Questions

What conditions are included in L65?

L65 includes conditions such as telogen effluvium, alopecia areata, and other nonscarring hair loss types that do not result in permanent scalp damage.

When should I use L65 codes?

L65 codes should be used when documenting cases of hair loss that are reversible and do not involve scarring, particularly when the cause is not yet determined.

What documentation is required for L65?

Documentation should include a detailed patient history, clinical findings, any diagnostic tests performed, and treatment plans to support the diagnosis of nonscarring hair loss.